Overall Survival Benefit of Radium-223 Chloride (Alpharadin™) in the Treatment of Patients with Symptomatic Bone Metastases in Castration-resistant Prostate Cancer (CRPC): a Phase III Randomized Trial (ALSYMPCA)
C. Parker, D. Heinrich, J.M. O'Sullivan, S. Fossa, A. Chodacki, T. Demkow, A. Cross, B. Bolstad, J. Garcia-Vargas, O. SartorVolume:
47
Year:
2011
Language:
english
DOI:
10.1016/s0959-8049(11)70100-9
File:
PDF, 50 KB
english, 2011
File converter
More search results
More benefits 
